Nicola Clear Stratgic Business Development

— Strategic Business Development

Nicola Clear is a strategic business development leader for NGT BioPharma Consultants.  Following 35+ years in pharmaceutical R&D and digital transformation with leadership experience across drug discovery and development, CMC, and operational / digital excellence at GSK then Pfizer. Nicola’s has influenced drug product design, portfolio and resource management, data analytics, and oncology CMC product strategies to accelerate products and workflows.

Nicola has led large-scale digital transformation programmes, embedding ML, predictive modelling, digital twins, and data-led decision-making into R&D and CMC workflows, with direct impact on portfolio prioritisation, resource forecasting, and annual operating budgets. This included management of complex global alliances, technology transfer and outsourcing, continuous manufacturing, and end-to-end reformulation and lifecycle strategy.

Now consulting, Nicola advises pharmaceutical and biotech organisations on digital maturity, R&D process redesign, portfolio and resource optimisation, and strategic growth. By combining a strong passion for networking with deep expertise in operational efficiency and the application of advanced digital and data technologies.

Now leading business development strategies that drive sustainable growth, strengthen partnerships, and translate innovation into measurable value.

Nicola Clear NGT Strategic Business Development